Search Results

Keywords: "United Kingdom"

Germany’s medical cannabis flower market shows signs of cooling

Germany imported 1,759 kilograms (3,878 pounds) of medical cannabis flower for pharmacy dispensing during the third quarter of 2020, new data from the Federal Institute for Drugs and Medical Devices (BfArM) shows. This represents a 28% decrease over the previous quarter but is 34% lower than the same quarter last year. However, for the January-September period, […]

Read More

Epidiolex maker GW Pharma reports record quarterly revenue of $137 million

United Kingdom-based GW Pharmaceuticals posted higher revenue in the quarter ended Sept. 30, largely driven by U.S. sales of its cannabidiol medicine Epidiolex. GW’s total revenue for the third quarter reached $137.1 million, about 16% more than the previous quarter’s $121.3 million. Epidiolex sales in the United States accounted for 87% of the company’s overall […]

Read More

Global small-scale cannabis cultivation survey could offer business insights

An international survey aims to uncover new information about small-scale cannabis cultivation around the world, and the research team’s findings could provide valuable information for both commercial marijuana producers and businesses that serve the home MJ cultivation market. More than 3,000 people have already responded to the latest International Cannabis Cultivation Questionnaire from the Global […]

Read More

WHO cannabis recommendations still face uphill battle for adoption

The World Health Organization’s cannabis scheduling recommendations appeared to have limited support at a United Nations Commission on Narcotic Drugs (CND) “intersessional” meeting on Thursday in Vienna. That means the proposals still face an uphill battle ahead of December’s expected vote. As a result, cannabis businesses counting on the adoption of all the WHO recommendations […]

Read More

Aphria joins crowded German cannabis flower market; sales to start in ‘weeks’

Canadian cannabis producer Aphria is joining the increasingly competitive German medical marijuana flower market. The company said this week it completed its first shipment of dried flower to its wholly owned German subsidiary, CC Pharma GmbH. Hendrik Knopp, managing director of Aphria Germany, told Marijuana Business Daily the company expects to have products available for […]

Read More

GW Pharmaceuticals cannabis drug gets regulatory OK in Australia

GW Pharmaceuticals’ plant-derived CBD drug Epidyolex received approval from Australia’s Therapeutic Goods Administration (TGA) to be used in treating seizures related to Lennox-Gastaut syndrome and Dravet syndrome for patients 2 and older. The approval is the third major global regulatory approval for Epidyolex, GW said in a news release. “The TGA approval is further proof […]

Read More

Macedonian medical cannabis could soon be available in Germany, Poland

PharmaCann Polska recently became the first company to obtain EU-Good Manufacturing Practice (EU-GMP) certification to produce medical cannabis extracts at its facility in North Macedonia, according to its CEO. That brings the Warsaw-headquartered company – along with its production facilities in North Macedonia – one step closer to being able to offer its medical cannabis […]

Read More

Cannabis opportunities growing in these five international markets

Patience might prove to be a virtue when it comes to the five nations outlined here. These countries don’t offer cannabis entrepreneurs an opportunity to cash in quickly—at least not yet. Rather, the five selected countries, which span from Europe to Latin America and Oceania, are worth keeping tabs on for their potential business opportunities […]

Read More

Top international cannabis opportunities

Not a week goes by without a prognosticator foretelling an international marijuana industry worth a bajillion dollars between five and 50 years from now. But what about today’s markets? It turns out there are some healthy, and growing, medical marijuana markets outside the United States and Canada—assuming you can look past the cannabis industry fan […]

Read More

Global Retreat: Canadian cannabis firms pull back global aspirations

Back in the early days of Canada’s regulated adult-use cannabis industry, some of the country’s biggest publicly traded marijuana producers discovered that investors rewarded international ambitions. The domestic recreational marijuana market that launched in October 2018 was exciting, of course, but that opportunity would always be limited by Canada’s relatively small population of around 38 […]

Read More

Chile health authority warns of ‘counterfeit’ cannabis medicines

The Public Health Institute of Chile (ISP) issued a warning recently about CBD products offered for sale online without a required sanitary registration. Many CBD products “suddenly disappeared” from the market after the ISP news release, local sources told Marijuana Business Daily. In recent months, the gray market had expanded considerably, according MJBizDaily’s second edition […]

Read More

Epidiolex maker GW Pharma turns in flat second quarter on pandemic impact

United Kingdom-based GW Pharmaceuticals posted marginal revenue growth in the second quarter over the previous quarter, citing challenges stemming from the COVID-19 pandemic. GW reported revenue of $121.3 million for the quarter ended June 30 – about the same as the previous period. GW’s quarterly net loss rose slightly to $8.8 million. By product, Epidiolex […]

Read More